Log In
BCIQ
Print this Print this
 

SB011

  Manage Alerts
Collapse Summary General Information
Company sterna biologicals GmbH & Co. KG
DescriptionDermal formulation of DNAyzme-based GATA binding protein 3 (GATA3) antagonist
Molecular Target GATA binding protein 3 (GATA3)
Mechanism of ActionGATA binding protein 3 (GATA3) antabonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today